PANDION THERAPEUTICS, INC. Earnings Per Share, Basic and Diluted
PANDION THERAPEUTICS, INC. reported Earnings Per Share, Basic and Diluted of -$3.17 per share for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-03-12
- PANDION THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.39.
- PANDION THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.51.
- PANDION THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$10.15.
- PANDION THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2019-12-31 was -$5.15.
- PANDION THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2020 was -$3.17.
- PANDION THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2019 was -$25.00.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$0.39 derived: net income ÷ weighted average shares · filed 2021-03-12 | -$0.89 derived: net income ÷ weighted average shares · filed 2021-03-12 | -$1.99 derived: net income ÷ weighted average shares · filed 2021-03-12 | -$3.17 10-K · filed 2021-03-12 |
| 2020-09-30 | -$0.51 10-Q · filed 2020-11-16 | -$1.95 derived: net income ÷ weighted average shares · filed 2020-11-16 | -$3.71 10-Q · filed 2020-11-16 | |
| 2020-06-30 | -$10.15 10-Q · filed 2020-08-31 | -$17.23 10-Q · filed 2020-08-31 | ||
| 2019-12-31 | -$5.15 derived: net income ÷ weighted average shares · filed 2021-03-12 | -$11.83 derived: net income ÷ weighted average shares · filed 2021-03-12 | -$18.14 derived: net income ÷ weighted average shares · filed 2021-03-12 | -$25.00 10-K · filed 2021-03-12 |
| 2019-09-30 | -$6.72 10-Q · filed 2020-11-16 | -$13.02 derived: net income ÷ weighted average shares · filed 2020-11-16 | -$19.91 10-Q · filed 2020-11-16 | |
| 2019-06-30 | -$6.30 10-Q · filed 2020-08-31 | -$13.19 10-Q · filed 2020-08-31 |